Goo-Hyun Kwon
Overview
Explore the profile of Goo-Hyun Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Lee S, Kwon G, Song S, Park J, Kim M, et al.
J Microbiol
. 2025 Mar;
63(2):e2411002.
PMID: 40044134
Synbiotics have become a new-age treatment tool for limiting the progression of metabolic dysfunction-associated steatotic liver disease; however, inclusive comparisons of various synbiotic treatments are still lacking. Here, we have...
2.
Oh K, Yoon S, Eom J, Lee K, Kwon G, Kim D, et al.
Eur J Med Chem
. 2025 Feb;
288:117385.
PMID: 39970728
Non-alcoholic fatty liver disease (NAFLD) is implicated in steatohepatitis (NASH), liver cirrhosis (LC) to hepatocellular carcinoma (HCC), sequentially. Herein, our aim was to unravel the nuanced key components (compounds, and...
3.
Oh K, Yoon S, Song S, Park J, Kim J, Kim M, et al.
Artif Cells Nanomed Biotechnol
. 2024 Oct;
52(1):500-511.
PMID: 39387711
Currently, the treatment of hepatocellular carcinoma (HCC) is yet to be determined, alternatively, flavonoids or alkaloids from nature have been considered as significant mediators against HCC. In the scenario, we...
4.
Kang E, Cha M, Kwon G, Han S, Yoon S, Lee S, et al.
Microbiome
. 2024 Sep;
12(1):181.
PMID: 39342324
Backrground: Akkermansia muciniphila, a next-generation probiotic, is known as a cornerstone regulating the gut-organ axis in various diseases, but the underlying mechanism remains poorly understood. Here, we revealed the neuronal...
5.
Sharma S, Gupta H, Kwon G, Lee S, Song S, Kim J, et al.
Clin Mol Hepatol
. 2024 Jul;
30(4):845-862.
PMID: 39048520
Background/aims: Shifts in the gut microbiota and metabolites are interrelated with liver cirrhosis progression and complications. However, causal relationships have not been evaluated comprehensively. Here, we identified complication-dependent gut microbiota...
6.
Lee S, Gupta H, Min B, Ganesan R, Sharma S, Won S, et al.
Artif Cells Nanomed Biotechnol
. 2024 Apr;
52(1):250-260.
PMID: 38687561
Despite many recent studies on non-alcoholic fatty liver disease (NAFLD) therapeutics, the optimal treatment has yet to be determined. In this unfinished project, we combined secondary metabolites (SMs) from the...
7.
The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology
Oh K, Eom J, Lee K, Kwon G, Yoon S, Song S, et al.
J Transl Med
. 2024 Mar;
22(1):279.
PMID: 38491465
No abstract available.
8.
Oh K, Yoon S, Eom J, Lee K, Kwon G, Kim D, et al.
J Transl Med
. 2024 Mar;
22(1):262.
PMID: 38462631
No abstract available.
9.
Oh K, Gupta H, Ganesan R, Sharma S, Won S, Jeong J, et al.
Artif Cells Nanomed Biotechnol
. 2023 May;
51(1):217-232.
PMID: 37129458
We comprised metabolites of gut microbiota (GM; endogenous species) and dietary plant-derived natural flavonoids (DPDNFs; exogenous species) were known as potent effectors against non-alcoholic fatty liver disease (NAFLD) network pharmacology...
10.
Oh K, Choi I, Gupta H, Raja G, Sharma S, Won S, et al.
Artif Cells Nanomed Biotechnol
. 2022 Dec;
51(1):1-12.
PMID: 36562095
We intended to identify favourable metabolite(s) and pharmacological mechanism(s) of gut microbiota (GM) for liver regeneration (LR) through network pharmacology. We utilized the gutMGene database to obtain metabolites of GM,...